Wild-type transthyretin cardiac amyloidosis in an elderly male patient: a case report. [PDF]
Zou X +6 more
europepmc +1 more source
To Silence or to Stabilize: That is the Question. [PDF]
Augusto JB.
europepmc +1 more source
Real-World Clinical Evidence With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy - A Contemporary Review. [PDF]
Izumiya Y +6 more
europepmc +1 more source
Invasive pressure-volume loop and PET-MR phenotyping in transthyretin cardiac amyloidosis: a multimodal imaging case report. [PDF]
Venkateshvaran A +4 more
europepmc +1 more source
Standardizing the Definition of Early Diagnosis in Wild-Type Transthyretin Amyloidosis. [PDF]
Tini G, Musumeci B.
europepmc +1 more source
Population diversity of the genetically determined expression in human tissues and its implications in TTR amyloidosis [PDF]
core +1 more source
Deciphering the binding mechanism of tafamidis to calf thymus DNA: multimodal spectroscopic, thermodynamic, and computational perspectives. [PDF]
Alossaimi MA +3 more
europepmc +1 more source
Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A Multicentric, Prospective Pilot Study for AMY-CCM Registry. [PDF]
Marchese P +19 more
europepmc +1 more source
Tafamidis and tafamidis meglumine for amyloid cardiomyopathy.
openaire +1 more source
Effect of β-Blockers on the Left Ventricular Strain in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis. [PDF]
Nishizawa RH +10 more
europepmc +1 more source

